Stigma and Inequality: The Hidden Harms Faced by UK Cannabis Patients
In this article we explore some new research which outlines the impact of stigma and inequality on medical cannabis patients in the UK.
35 pieces.
In this article we explore some new research which outlines the impact of stigma and inequality on medical cannabis patients in the UK.
In this articles we explore how Trump's new position on cannabis might impact the US cannabis policy landscape.
Critical DEA cannabis hearing delayed due to 43,500 public comments. The decision could now sit with Trump or Harris
Matt Rees explores whether the provisions of the recently announced £5 million pound fund are enough to tackle drug deaths in the UK
With all of their recent announcements Cancard have been busy bees so far this year. Let's take a look at what they've been up to...
Why are the conservatives cracking down on drugs and what does this mean for UK drug policy?
Statistics suggest that LGBTQ+ individuals use drugs at higher levels than straight people, but what is it that drives this? Megan Townsend takes a look...
This month, medicinal cannabis organisation Cancard announced a collaborative project with Grow Lab Organics to enable a licensed medicinal cannabis farm to…
On the 1st July 2023 Australia became the first country to legalise psychedelics for certain mental health conditions. However, the move has been met with…
Psych Symposium returns to the British Museum in London on the 6th July with an impressive line-up of panels and speakers
With one of the two prescribers in the UK set to retire at the end of July, up to 20 children face losing access to their medical cannabis prescriptions
'The Drug Users Bible', an essential harm reduction resource by Dominic Milton Trott, is now available for free via Volteface
Are the Green Party the answer to our drug policy reform problems? Matt Rees explores...
How can cannabis reformers learn from the reaction to the 'vaping epidemic? Matt Rees explores...
The upcoming ban on possession of Nitrous Oxide is the latest in a long history of expert advice and evidence being ignored in UK drugs policy-making, in favour…
On 15th May, The Times released an article titled: 'How ketamine became the UK's hidden campus killer', examining ketamine use in UK universities and the turn…
Paul North reflects on the progress of UK medical cannabis since 2018, and proposes solutions for its future...
UK charity Wellbeing of Women is looking into new treatments for endometriosis and its associated symptoms, including cannabis medicines.
George Smith takes us into the underground dark web drug marketplaces, with some surprising initiatives that could teach legal markets a thing or two...
The number of arrests UK police forces made for drug driving has more than doubled in the last four years. Lisa Darvill explains why we should be concerned.
Their deaths, in separate circumstances and different places are equally tragic and serve as stark reminders of the human cost of our 50 year experiment at drug…
It would be difficult to trace the harm reduction movement back to one specific cause, as it has roots in so many different activist groups. The movement goes…
Prescriptions for benzos have fallen, but with no measures taken to limit demand, many patients are turning to the illegal marketplace.
As the hype around psychedelics picks up pace, it’s easy to forget that at the centre of this research are the patients themselves...
Significant new research from the APPG for drug policy reform shows decisive support for drug law reform amongst red wall voters...
The policy debate around drugs in the UK is muddled and tripolar. It’s split between people who believe in legalization, decriminalization, and continuing…
The twentieth century was a watershed in the history of hemp stigmatisation...
So, how has COVID impacted rave culture?
As part of our week long spotlight on women in the medical cannabis sector we have had the pleasure of interviewing Hannah Deacon, Director of Maple Tree...
This week at Volteface we are spotlighting the work of women in the medical cannabis sector. In this interview Carly Barton, Director of Cancard, has shared
Medical Cannabis Awareness Week has kicked off, making three years since cannabis was legalised for medical purposes in the UK.
As the Conservative party conference concludes, it's an important time to reflect on the drug related deaths that took place in 2020.
This year, during National Recovery Month, members of the Humankind community have collectively walked over 1000 miles to raise awareness.
Drug policy is a complex sphere to navigate for a whole host of reasons. The most important and difficult being that drug use is perceived to be a moral…
It’s been a great start to the year for social justice in cannabis reform, with the expungement of 500,000 low-level cannabis offences in the state of Illinois…